Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDestiny Pharma. Share News (DEST)

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.00
Bid: 16.50
Ask: 17.50
Change: -0.50 (-2.86%)
Spread: 1.00 (6.061%)
Open: 17.50
High: 17.50
Low: 17.00
Prev. Close: 17.50
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Dianomi swings to loss; Epwin revenue up

Wed, 20th Sep 2023 14:27

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Epwin Group PLC - Solihull, England-based building products manufacturer - Revenue in six months to June 30 up 1.1% to GBP180.0 million from GBP178.0 million. Pretax profit flat at GBP7.9 million. Interim dividend per share rises 5.3% to 2.0 pence from 1.9p a year prior. "Q3 trading to date has been encouraging with profitability ahead of 2022," Epwin adds. It expects to report annual results in line with market expectations. Underlying operating profit expectations stand at GBP24.0 million, which would represent a 12% rise from GBP21.5 million in 2022.

----------

Dianomi PLC - London-based digital advertising platform - Revenue in half-year ended June 30 drops 18% to GBP14.8 million from GBP18.0 million, amid "decline in traffic volumes across the group's direct publisher inventory". Swings to pretax loss of GBP2.1 million from profit of GBP897,000 a year earlier. "We are mindful of an environment that continues to be challenging and the need to adapt. The group's operational cost base has been streamlined and optimised following the restructuring of the group's global management and sales teams, resulting in an annualised cost reduction of GBP1 million. However, in spite of a difficult backdrop, I am pleased to report that Dianomi continues to attract new clients and now counts all 10 of the top 10 US asset managers as clients," Chief Executive Rupert Hodson says. Dianomi expects a profitable second-half. In addition, the firm explained it has agreed a contract amendment with "one of its largest and longest standing publisher partners". While bullish that the amendment is good news in the long-term, Dianomi noted the arrangement hurt its adjusted earnings before, interest, tax, depreciation and amortisation for the six months of 2023. "There will be a short-term impact on cash of GBP500,000 in the current financial year which will unwind during 2024," the firm says. Dianomi says minimum traffic levels were not met, meaning it was overpaid by the publisher to tune of USD1 million. Dianomi adds: "Following discussions, the company and the publisher have entered into an amendment to the agreement whereby Dianomi has agreed not to recoup the overpayment, in return for which the publisher will provide Dianomi with an enhanced revenue share as from 1 July 2023 and, in addition to its existing permanent ad units, will provide Dianomi with additional premium ad inventory, including a new in-article unit."

----------

Ten Entertainment Group PLC - ten-pin bowling operator - Total sales in half-year ended July 2 improve 3.3% on-year to GBP65.3 million from GBP63.2 million a year earlier. Pretax profit, however, falls by a quarter to GBP15.8 million from GBP21.0 million. The prior year's bottom line got a GBP4.4 million boost from a claim for reduced rate of VAT on bowling. Ten Entertainment adds: "An ongoing focus on refurbishment, customer service and digital communications gives us confidence that we can continue to deliver like-for-like sales growth from the existing estate through addition of new activities and focus on the core entertainment experience. Cost inflation remains manageable, and we expect a slightly lower than the UK headline rate as a function of our long-term supplier strategy." The firm adds year-to-date like-for-like sales are 4.7% higher.

----------

DP Aircraft I Ltd - Guernsey-based aircraft leasing company - Lease rental in six months to June 30 falls 43% to USD4.3 million from USD7.6 million a year earlier. DP Aircraft swings to a pretax loss of USD4.1 million from profit of USD3.0 million. "There has been a continued improvement in the global aviation market following the challenges resulting from the effects of the Covid-19 pandemic. Recent sentiment on airline and related stocks has been more optimistic. The Ukraine war has not had as significant an impact on the industry as expected. With Covid-19 restrictions in China being lifted there is cause for some optimism in tourism numbers from that market in Thailand going forward," DP Aircraft says.

----------

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Reports licence fee income of GBP831,552 in first half ended June 30, against none a year earlier. Pretax loss narrows to GBP3.1 million from GBP3.8 million. CEO Chris Tovey says: "The partnering of NTCD-M3 and the associated fundraising during the period demonstrate our ability to generate significant value from our assets, and have positioned the company for success as we advance the Phase 3 development programme for M3 and intensify our partnering activities for our lead asset, XF-73 nasal. The company is now funded through to Q1 2025, allowing us to deliver our planned activities."

----------

Ethernity Networks Ltd - supplier of data processing semiconductor technology for networking appliances - Revenue in first half ended June 30 surges 98% to USD1.4 million from USD704,853. Pretax loss, however, widens to USD3.6 million from USD3.5 million. Reports financing income of just GBP322,814, down from GBP1.2 million a year earlier. Ethernity adds: "The company is targeting the achievement of positive cash flow generation from operations during the second half of 2023 by continuing to fulfil customers' orders and from anticipated revenue from new contracts, in combination with a reduction in expenses."

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
20 May 2022 16:00

UK shareholder meetings calendar - next 7 days

Monday 23 May 
Brewin Dolphin Holdings PLCGM re acquisition by RBC Wealth Management
Digital 9 Infrastructure PLCAGM
Empiric Student Property PLCAGM
TMT Investments PLCAGM
Tuesday 24 May 
4imprint Group PLCAGM
Afentra PLCAGM
Artisanal Spirits Co PLCAGM
Bidstack Group PLCAGM
Epwin Group PLCAGM
FDM Group Holdings PLCAGM
Forterra PLCAGM
Harworth Group PLCAGM
Henderson High Income Trust PLCAGM
Hill & Smith Holdings PLCAGM
Hilton Food Group PLCAGM
Horizonte Minerals PLCAGM
Judges Scientific PLCAGM
Pebble Group PLCAGM
Quarto Group IncAGM
Restaurant Group PLCAGM
Riverstone Energy LtdAGM
Shell PLCAGM
Thungela Resources LtdAGM
Vector Capital PLCAGM
WPP PLCAGM
Wednesday 25 May  
Access Intelligence PLCAGM
Amur Minerals CorpAGM
Aston Martin Lagonda Global Holdings PLCAGM
Bakkavor Group PLCAGM
Bango PLCAGM
Bodycote PLCAGM
Eleco PLCAGM
International Public Partnerships LtdAGM
Intertek Group PLCAGM
M&G PLCAGM
Manx Financial Group PLCAGM
Mortgage Advice Bureau Holdings PLCAGM
Property Franchise Group PLCGM re final 2021 dividend
Regional REIT LtdAGM
Sabre Insurance Group PLCAGM
Trustpilot Group PLCAGM
Tullow Oil PLCAGM
Zenova Group PLCAGM
Zotefoams PLCAGM
Thursday 26 May 
Aminex PLCAGM
Bank of Ireland Group PLCAGM
Belvoir Group PLCAGM
Central Asia Metals PLCAGM
Curtis Banks Group PLCAGM
Diaceutics PLCAGM
Duke Royalty LtdEGM re fundraise
East Star Resources PLCAGM
Energean PLCAGM
Henry Boot PLCAGM
Hochschild Mining PLCAGM
Legal & General Group PLCAGM
National World PLCAGM
Ocean Wilsons Holdings LtdAGM
OnTheMarket PLCGM re cancellation of capital
Prudential PLCAGM
S&U PLCAGM
Staffline Group PLCAGM
Strix Group PLCAGM
WAG Payment Solutions PLCAGM
Yu Group PLCAGM
Friday 27 May 
AG Barr PLCAGM
Big Technologies PLCAGM
Coca-Cola Europacific Partners PLCAGM
Destiny Pharma PLCAGM
Hostmore PLCAGM
Lancashire Holdings LtdAGM
Lekoil LtdEGM re appointment and remuneration of auditors
LSL Property Services PLCAGM
Malin Corp PLCAGM
Old Mutual LtdAGM
Oxford BioMedica PLCAGM
Renewables Infrastructure Group LtdAGM
Spectris PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
12 May 2022 19:45

TRADING UPDATES: Belluscura to raise GBP5 million; React buys

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
3 May 2022 21:55

TRADING UPDATES: Vela, Standard Life Investments up portfolio value

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
3 May 2022 12:16

Destiny Pharma appoints Yuri Martina as chief medical officer

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the appointment of Dr Yuri Martina as its chief medical officer on Tuesday.

Read more
12 Apr 2022 12:42

EARNINGS UPDATES: Parsley Box widens loss; M Winkworth profit doubles

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
5 Apr 2022 16:34

UK earnings, trading statements calendar - next 7 days

Wednesday 6 April  
Applied Graphene Materials PLCHalf Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Hilton Food Group PLCFull Year Results
Hyve Group PLCTrading Statement
Topps Tiles PLCTrading Statement
Wentworth Resources PLCFull Year Results
Thursday 7 April 
Alpha Financial Markets Consulting PLCTrading Statement
Attraqt Group PLCFull Year Results
Entain PLCQ1 Results
Robert Walters PLCQ1 Results
Tracsis PLCHalf Year Results
Friday 8 April 
CMC Markets PLCTrading Statement
Ferrexpo PLCTrading Statement
Monday 11 April 
Tortilla Mexican Grill PLCFull Year Results
Sirius Real Estate LtdTrading Statement
Tuesday 12 April 
ASOS PLCHalf Year Results
Cambridge Cognition Holdings PLCFull Year Results
Destiny Pharma PLCFull Year Results
easyJet PLCTrading Statement
Filta Group Holdings PLCFull Year Results
JD Sports Fashion PLCFull Year Results
Liontrust Asset ManagementTrading Statement
M Winkworth PLCFull Year Results
Moneysupermarket.com Group PLCTrading Statement
Nanoco Group PLCHalf Year Results
Pennon Group PLCTrading Statement
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
25 Mar 2022 14:26

IN BRIEF: Destiny Pharma raises GBP450,000 through open offer

Destiny Pharma PLC - a clinical-stage biotechnology company based in Brighton, England - Raises total gross proceeds of GBP450,000 through its open offer. Has conditionally raised total gross proceeds of GBP6.5 million through its placing, subscription, and open offer. Says it has applied for the admission of 12.9 million shares, consisting of 11.9 million placing shares, 140,000 subscription shares and 909,007 open offer shares.

Read more
8 Mar 2022 19:38

IN BRIEF: Destiny Pharma to raise GBP7.0 million for asset trials

Destiny Pharma PLC - clinical-stage biotechnology company based in Brighton, England - Intends to raise GBP7.0 million through a placing of 11.9 million shares at 50 pence each, subscription for 140,000 shares and an open offer for 2.0 million shares.

Read more
8 Mar 2022 13:55

Destiny Pharma to raise up to £7m in discounted fundraising

(Sharecast News) - Clinical stage biotechnology company Destiny Pharma said on Tuesday that it was looking to raise up to £7m in a conditional fundraising to continue progress towards Phase 3 in its two lead clinical assets.

Read more
8 Feb 2022 20:36

IN BRIEF: Destiny Pharma receives Europe watchdog XF-73 boost

IN BRIEF: Destiny Pharma receives Europe watchdog XF-73 boost

Read more
8 Feb 2022 15:07

Destiny upbeat on nasal gel feedback from EMA

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma said on Tuesday that it has received positive scientific advice from the European Medicines Agency (EMA), following its review of its proposed phase 3 clinical programme design.

Read more
1 Feb 2022 14:57

Destiny successfully completes preclinical study of dermal formulation

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the successful completion of a preclinical safety study with a novel 'XF-73' dermal formulation on Tuesday.

Read more
24 Jan 2022 13:44

Destiny Pharma reports success in US C. diff trial

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the successful outcome of its cooperative research and development agreement with the US Department of Veterans Affairs (VA) on Monday.

Read more
21 Jan 2022 14:36

IN BRIEF: Destiny Pharma notes study that shows need for XF platform

IN BRIEF: Destiny Pharma notes study that shows need for XF platform

Read more
17 Jan 2022 18:40

TRADING UPDATES: MP Evans declares special payout as production rises

TRADING UPDATES: MP Evans declares special payout as production rises

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.